Hologic Opens New Innovation Center in France

Rhea-AI Summary

Hologic, Inc. (NASDAQ: HOLX) has launched a new Innovation Center in Aix-en-Provence, France, marking a significant expansion of its commitment to women's health. This facility, which serves as the new French headquarters, will focus on ultrasound, interventional, and surgical solutions in breast health care. Following the acquisition of SuperSonic Imagine in 2019, Hologic aims to enhance access to innovative healthcare technologies in the EMEA region. The investment reflects Hologic's mission to improve the health of 3.9 billion women worldwide.

Positive

• Establishment of a new Innovation Center enhances Hologic's R&D and market presence.
• Investment supports development of ultrasound and surgical solutions for women's health.
• Facility serves as the new headquarters in France, aiming to improve health outcomes.

Negative

• None.

--The state-of-the-art facility in Aix-en-Provence also serves as the new headquarters of Hologic France--

AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, opened its new Innovation Center today in Aix-en-Provence, France. This announcement follows Hologic’s 2019 acquisition of Aix-en-Provence-based SuperSonic Imagine and further demonstrates Hologic’s commitment to the EMEA region. The new commercial office, training and research and development facility will support Hologic’s ultrasound, interventional and surgical solutions across the continuum of breast health care.

Innovation Center in Aix-en-Provence, France (Photo: Business Wire)

“Hologic is a global champion for women’s health and brings innovative technologies to healthcare professionals helping them detect, diagnose and treat illnesses and health conditions earlier and more effectively,” said Antoine Bara, General Manager of Hologic France. “The significant investment being made in France is another example of Hologic’s relentless commitment to innovation and its mission to improve the health and well-being of 3.9 billion woman globally.”

The facility also will serve as Hologic’s new French headquarters. They will operate as a hub to bring new innovations to market, expanding access to new technologies in the European market, and building the expertise of healthcare professionals. This investment will bring to life Hologic's ambition to improve women’s health globally by developing innovative products and services that drive certainty in outcomes for patients and providers.

Hologic is a champion of women’s health and recently launched the Hologic Global Women’s Health Index in France. The Index is a multiyear effort that measures five dimensions of health which explain 80% of women’s life expectancy: Preventive Care, Basic Needs, Opinions of Health & Safety, Individual Health, and Emotional Health. It provides a global, and comprehensive data set from the lived experiences of women and girls to guide world leaders, policymakers, and women. The data set helps to understand the issues and promote action to improve the quality of life and life expectancy of women worldwide. It represents the knowledge, attitudes, and behaviors of 2.5 billion women aged 15+. More information on the Index and specific data for France is available on request.

For more information on Hologic, visit www.hologic.fr.

About Hologic, Inc.

Hologic, Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment. Its advancements include creation of the world’s first commercial 3D mammography system to detect breast cancer; leadership in testing for cervical cancer, sexually transmitted infections, respiratory illnesses and the virus that causes COVID-19; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding.

Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to France@hologic.com.

SOURCE: Hologic, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005088/en/

Media Contact:

Jane Mazur

Head of Corporate Communications

jane.mazur@hologic.com

Investor Contact:

Ryan Simon

Vice President, Investor Relations

ryan.simon@hologic.com

Source: Hologic, Inc.

FAQ

What is the purpose of Hologic's new Innovation Center in Aix-en-Provence?

The Innovation Center aims to enhance R&D and support ultrasound and surgical solutions in women's health.

When did Hologic open its new Innovation Center?

Hologic opened the new Innovation Center on the date of the press release.

What areas will the new facility in France focus on?

The facility will focus on ultrasound, interventional, and surgical solutions for breast health care.

What was the significance of Hologic's acquisition of SuperSonic Imagine in 2019?

The acquisition allowed Hologic to strengthen its offerings in breast health technology and expand in the EMEA region.

How does Hologic's investment in France align with its global mission?

The investment reflects Hologic's commitment to improving women's health and expanding access to innovative technologies.